2018 Agenda

The 2018 AgChem Summit agenda will feature speakers from TSG, Marrone Bio Innovations, APIS, BASF and more. 

Day 1 | May 3rd

Registration & Welcome

  1. Registration & Welcome | Exhibit Hall Opens

  2. Welcome and Opening Remarks

Session I: US Regulatory Landscape

  1. Coming Soon!

  2. Regulatory Update from the USDA

  3. Networking Break

  4. Defining, Registering, and Ensuring Regulatory Compliance for Biological Products

    Dr. Sheryl Reilly | Senior Regulatory Consultant of TSG USA

    Biological products including biochemicals, microbials, and biostimulants, are derived from natural materials, such as plants, animals, fungi, and some minerals. Regulatory requirements are based on product type, claims, and intended uses. As with other plant protection and health products, biological products must meet safety and efficacy requirements before they can be registered and sold to consumers. Depending on the type of biological product, it may be registered at the federal level by the US Environmental Protection Agency (EPA), at the state level, or both. While federal or state registration is the first step in bringing biological products to market, the registrations must also be maintained annually to ensure continued compliance. This includes fulfilling reporting requirements and paying appropriate maintenance fees. The EPA and states monitor products under their regulatory purview for compliance to ensure that the regulated community obeys environmental laws and regulations. Compliance monitoring can occur on-site, where the product is being used, or off-site, such as during laboratory audits, and record reviews, or when following up on tips or complaints. 

  5. Legislation and Policy Impacting Regulation of Biologicals

    Jeff Blackwood | Senior Manager of Government Affairs of BASF

    • Pesticide Registration Improvement Act
    • 2018 Farm Bill
    • Agency Actions
  6. Panel Conversation with Session Presenters

    Panelists: TSG, BASF

    Coming soon!

  7. Lunch Break

Session II: Market Development and Overview

  1. Experiences in Manufacturing and Formulation of New Biologicals

    Robert Kennedy, PhD. | Chief Scientific Officer of Vestaron

    • Formulation and Application Practices for Efficacy
    • LC vs WG manufacturing considerations

    Vestaron is introducing a new biopesticide SPEAR™ that is based on a peptide isolated from spiders. While these peptides are very potent insecticides presenting them to insects in a way that they are bioavailable. SPEAR™ is active both topically and orally however formulation and application differs for these two modes of presentation. In the course of this presentation Vestaron learnings with a soluble granule and a liquid concentrate will also be discussed.

  2. Challenges within the International Markets

    Dr. Wendelyn Jones | Director Global Policy and Scientific Affairs of DuPont Crop Protection

    • Experience and challenges with illegal and counterfeit products
    • Regulatory considerations
    • This talk will cover China, Brazil and India
  3. Networking Break

Session III: International Update

This session will focus on regulations, trends and challenges in EU, Asia and Latin America.

Moderator: Dr. Wendelyn Jones, Director Global Policy and Scientific Affairs, DuPont 

  1. Complexity of Biological Products Registration Process in Brazil

    Dr. Mariola Kopcinski | Director Scientific Alliances of Plant Health Care

    Regulatory process in Brazil is extremely complex, which requires authorization from four agencies (MAPA, IBAMA, ANVISA, CNTBio)   

    The Experimental Use Permit (RET) takes several months and can only be received if company has established legal presence in Brazil or through consulting companies

    Efficacy trials are required for the registration in Brazil, and there are very strict rules which have to be followed or trials will not be accepted

    OECD guidance has to be used for all the regulatory studies, and US methodology and guidance is usually not sufficient for Brazilian registration

  2. European Regulatory Landscape & REFIT Initiative

    José Carvalho, PhD | Head of Global Business Development Agro Dossiers of Knoell Group

    • The biologicals registration in Europe: main differences to the USA
    • The REFIT initiative of the EU Commission: plant protection products and MRLs regulations
    • European MRLs System and interplay with biological products registered in non-EU countries impact on Food trade/exports

Session IV: Efficacy and Best Practices

  1. Insect Control with Biologicals and Effectiveness

    • Public trust and effectiveness
    • Resistance and challenges
    • Adaptability
  2. Pest Management Control

    • Best procedures
    • Actions to take for the use of biologicals
    • Crops that will benefit for the use of biologicals 
  3. Closing Remarks

  4. Welcome Reception

Day 2 | May 4th

Exhibit Hall Open & Breakfast

  1. Exhibit Hall Open

  2. Welcome

    Smithers Viscient

Session V: Biological Products in a “Green” Era

  1. Definitions of Biopesticides, Biocides, Biostimulants in a Broad Market

  2. Green Chemistry Regulations and the Differentiation with Biologicals

  3. Panel: Finding Balance Between Regulations for Demand of Greener Products

  4. Networking & Coffee Break

Session VI: Testing for Biologicals

  1. Risk Assessment and Data Management for Biologicals

  2. Rethinking Ecological Risk Assessment for Microbial Pesticides

    Dr. Mark Whittaker | Managing Director of APIS

    Standard ecotoxicology studies designed for agrochemicals are often unsuitable for the ecological risk assessment of microbial pesticides. In some cases, modifications to the protocols will address these deficiencies, but in others the test organisms are fundamentally unsuitable models for detecting adverse effects from the use of this class of biopesticides.

  3. Challenges with Crop Protection Testing for Biologicals

    • Analytical methods biologicals - risk and efficacy
    • Development and consideration for biologicals
    • Pitfalls to watch out when placing trials for biological products
  4. Coming Soon!

  5. Lunch Break

Session VII: RNAi Interference

  1. RNAi for Biologicals

    Dr. Paul Reibach | Technical Director Chemistry of Smithers Viscient

    • Impacts on crop protection  and specific uses
    • Risk assessment and developments
  2. Coming Soon!

  3. Coming Soon!

Session VIII: Next Generation of Biologicals

  1. Recent Advances in the Development of Biopesticides and Expectations for the Future

    Timothy Johnson, Ph.D. | VP Field Development and Technical Services of Marrone Bio Innovations

    During the past 30 years the crop protection business has been undergoing a continuous realignment away from the use of active ingredients discovered in the mid-20th century to more target specific and environmentally friendly pesticides. This realignment has occurred alongside a tremendous consolidation of the industry as well as a merging of interests between seed and chemical companies and the use of genetic traits on broad acre crops.  Often overlooked during this period is the growth of organic agriculture and the number of biologically based pesticides (biopesticides) used in both conventional and organic production that have largely been developed by smaller and more entrepreneurial companies.  This presentation will review where we are, how we got to where the biopesticide industry is today and discuss possible future directions regarding target pests, crops and delivery methods.  Several case studies will be described in detail including management of invasive pests such as spotted wing drosophila on fruit and berries, zebra mussel in industrial water uses, key pests such as corn rootworm and key diseases and plant parasitic nematodes in broad acre crops.  

  2. Closing Remarks